Leaderboards/Lung Cancer Diagnosis and Treatment

Lung Cancer Diagnosis and Treatment

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Tyler B. Kratzer
American Cancer Society
2
Jannat Rosul Nisha
Northern University Bangladesh
3
Adam H. Fox
Medical University of South Carolina
4
Goram Mufarah Alshmrani
Lancaster University
5
Hanbo Pan
Shanghai Jiao Tong University
6
Olga Maria Dona Lemus
University of Miami
7
Shi B. Chia
University of Colorado Anschutz Medical Campus
8
Chuang Niu
Rensselaer Polytechnic Institute
9
Rafael Paez
Vanderbilt University Medical Center
10
Nicolas Captier
Inserm

Papers

1
Lung cancer statistics, 2023
Cancer|2024
457 cit.
2
Adaptive Radiotherapy: Next-Generation Radiotherapy
Cancers|2024
111 cit.
3
Deep Learning-Driven Lung Cancer Detection: Integrating Image Processing and Web-Based Visualization
Unknown Journal|2025
103 cit.
4
Publication in Nature (2025) [55 citations, W4412737166]
Nature|2025
55 cit.
5
Publication in Nature Communications (2025) [50 citations, W4406290723]
Nature Communications|2025
50 cit.
6
Medical multimodal multitask foundation model for lung cancer screening
Nature Communications|2025
40 cit.
7
Publication in American Journal of Respiratory and Critical Care Medicine (2025) [27 citations, W4411045305]
American Journal of Respiratory and Critical Care Medicine|2025
27 cit.
8
Publication in Trials (2024) [18 citations, W4391028963]
Trials|2024
18 cit.
9
Publication in Clinical Lung Cancer (2024) [16 citations, W4393538000]
Clinical Lung Cancer|2024
16 cit.
10
Publication in Experimental Hematology and Oncology (2024) [11 citations, W4397014719]
Experimental Hematology and Oncology|2024
11 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Daniel Tse
Google (United States)
2
Colin Jacobs
Radboud University Nijmegen
3
Steven Horng
Beth Israel Deaconess Medical Center
4
Lenora A. Pluchino
National Comprehensive Cancer Network
5
Lisa Hang
National Comprehensive Cancer Network
6
Matthew P. Lungren
Microsoft (United States)
7
Elizabeth Smyth
National Health Service
8
Wen‐Zhao Zhong
Guangdong Academy of Medical Sciences
9
Geert Litjens
Radboud University Nijmegen
10
Alberto Cruz‐Bermúdez
Hospital Universitario Puerta de Hierro Majadahonda

Papers

1
Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network|2022
1.7k cit.
2
Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Annals of Oncology|2022
1.4k cit.
3
Non–Small Cell Lung Cancer, Version 4.2024
Journal of the National Comprehensive Cancer Network|2024
756 cit.
4
Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Annals of Oncology|2022
656 cit.
5
Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network|2023
520 cit.
6
Adolescent and Young Adult (AYA) Oncology, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network|2023
129 cit.
7
NCCN Guidelines® Insights: Management of Immunotherapy-Related Toxicities, Version 2.2024
Journal of the National Comprehensive Cancer Network|2024
107 cit.
8
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with gastric cancer
ESMO Open|2024
90 cit.
9
Erlotinib versus gemcitabine plus cisplatin as neoadjuvant treatment of stage IIIA-N2 EGFR-mutant non-small-cell lung cancer: final overall survival analysis of the EMERGING-CTONG 1103 randomised phase II trial
Signal Transduction and Targeted Therapy|2023
77 cit.
10
NCCN Guidelines® Insights: Hematopoietic Growth Factors, Version 1.2022
Journal of the National Comprehensive Cancer Network|2022
76 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Solange Peters
University Hospital of Lausanne
2
Philippe Lambin
Maastricht University Medical Centre
3
Ronald M. Summers
National Institutes of Health Clinical Center
4
Suresh Senan
Amsterdam Neuroscience
5
Matthijs Oudkerk
University Medical Center Groningen
6
K. Yokoi
Saga University
7
Miranda Hughes
National Comprehensive Cancer Network
8
Hisao Asamura
Keio University
9
Trond‐Eirik Strand
UiT The Arctic University of Norway
10
William D. Travis
Memorial Sloan Kettering Cancer Center

Papers

1
Deep Convolutional Neural Networks for Computer-Aided Detection: CNN Architectures, Dataset Characteristics and Transfer Learning
IEEE Transactions on Medical Imaging|2016
5.8k cit.
2
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach
Nature Communications|2014
5.1k cit.
3
The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer
Journal of Thoracic Oncology|2016
4.6k cit.
4
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
American Journal of Respiratory and Critical Care Medicine|2013
4.3k cit.
5
Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial
New England Journal of Medicine|2020
3.5k cit.
6
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Annals of Oncology|2016
2.6k cit.
7
Alectinib versus Crizotinib in Untreated <i>ALK</i>-Positive Non–Small-Cell Lung Cancer
New England Journal of Medicine|2017
2.5k cit.
8
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Annals of Oncology|2017
2.3k cit.
9
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Annals of Oncology|2018
2.3k cit.
10
Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial
The Lancet|2019
1.9k cit.

Reagents for Lung Cancer Diagnosis and Treatment

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 67

COL3A1 Antibody

Cited in 5 papers
#30565$317
View Evidence →
Cell Signaling TechnologyEvidence 63

DNA Purification Buffers and Spin Columns (ChIP, CUT&RUN, CUT&Tag)

Cited in 5 papers
#14209$131
View Evidence →
Cell Signaling TechnologyEvidence 66

FXR2 Antibody

Cited in 5 papers
#4247$317
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 66

Cas9 (S. pyogenes) (D8Y4K) Rabbit Monoclonal Antibody (SignalFlex™ mFluor™ Violet 510 Conjugate)

Cited in 7 papers
#38831$458
View Evidence →
Cell Signaling TechnologyEvidence 68

PD-L1 (E1L3N) Rabbit Monoclonal Antibody

Cited in 6 papers
#13684$1,881,327
View Evidence →
Leica BiosystemsEvidence 78

Anti-CD4 and CD8 duo pack Monoclonal Antibody, Unconjugated

Cited in 5 papers
#NCL-CD4/CD8d
View Evidence →